<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>9</volume><submitter>Haslbeck FB</submitter><funding>Vontobel-Stiftung</funding><pubmed_abstract>Impaired neurodevelopment is increasingly recognized as a major health issue in children born prematurely. Creative music therapy (CMT) intends to prevent and or reduce neurobehavioral deficits in pre-term infants using musical stimulation and socio-emotional co-regulation. We conducted a randomized, clinical pilot CMT trial to test feasibility and to examine long-term neurodevelopmental outcomes in pre-term infants (NCT02434224: https://clinicaltrials.gov/ct2/show/NCT02434224). Eighty-two pre-term infants were randomized either to CMT or standard care. A specially trained music therapist provided family-integrating CMT via infant-directed singing during hospitalization. Fifty-six infants underwent follow-up at 2 years of corrected age. No significant beneficial nor adverse effects of CMT were identified in routine clinical neurodevelopmental measures (Bayley-III Scales of Infant and Toddler Development and the standardized neurological examination). Longer term follow-up (5 years) and larger future studies are recommended to elucidate possible long-term effects of music in relation to more sensitive outcomes including executive function, detailed language processing and social-emotional development.</pubmed_abstract><journal>Frontiers in pediatrics</journal><pagination>660393</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8249730</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Creative Music Therapy and Neurodevelopmental Outcomes in Pre-term Infants at 2 Years: A Randomized Controlled Pilot Trial.</pubmed_title><pmcid>PMC8249730</pmcid><pubmed_authors>Natalucci G</pubmed_authors><pubmed_authors>Hagmann C</pubmed_authors><pubmed_authors>Bucher HU</pubmed_authors><pubmed_authors>Haslbeck FB</pubmed_authors><pubmed_authors>Bassler D</pubmed_authors></additional><is_claimable>false</is_claimable><name>Creative Music Therapy and Neurodevelopmental Outcomes in Pre-term Infants at 2 Years: A Randomized Controlled Pilot Trial.</name><description>Impaired neurodevelopment is increasingly recognized as a major health issue in children born prematurely. Creative music therapy (CMT) intends to prevent and or reduce neurobehavioral deficits in pre-term infants using musical stimulation and socio-emotional co-regulation. We conducted a randomized, clinical pilot CMT trial to test feasibility and to examine long-term neurodevelopmental outcomes in pre-term infants (NCT02434224: https://clinicaltrials.gov/ct2/show/NCT02434224). Eighty-two pre-term infants were randomized either to CMT or standard care. A specially trained music therapist provided family-integrating CMT via infant-directed singing during hospitalization. Fifty-six infants underwent follow-up at 2 years of corrected age. No significant beneficial nor adverse effects of CMT were identified in routine clinical neurodevelopmental measures (Bayley-III Scales of Infant and Toddler Development and the standardized neurological examination). Longer term follow-up (5 years) and larger future studies are recommended to elucidate possible long-term effects of music in relation to more sensitive outcomes including executive function, detailed language processing and social-emotional development.</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021</publication><modification>2024-11-08T18:42:42.652Z</modification><creation>2022-02-10T18:29:35.989Z</creation></dates><accession>S-EPMC8249730</accession><cross_references><pubmed>34222141</pubmed><doi>10.3389/fped.2021.660393</doi></cross_references></HashMap>